![](/img/cover-not-exists.png)
Management of type 2 diabetes with Fixed-Ratio combination insulin degludec/liraglutide (IDEGLIRA) versus Basal-Bolus therapy (INSULIN GLARGINE U100 PLUS INSULIN ASPART): A Short-Term Cost-Effectiveness analysis in the UK setting
Drummond, RS, Malkin, SJP, Du Preez, M, Lee, XY, Hunt, BLanguage:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13375
Date:
May, 2018
File:
PDF, 1.06 MB
english, 2018